Replies to post #62 on Ocugen Inc (OCGN)

[zino]

FDA has changed the guidelines for cartilage repair studies since Histogenics started its trials
https://www.bizjournals.com/boston/news/2018/09/05/histogenics-to-seek-fda-approval-for-cell-therapy.html